Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination

BACKGROUND: Activating Transcription Factor (ATF) 3 is a key regulator of the cellular integrated stress response whose expression has also been correlated with pro-apoptotic activities in tumour cell models. Combination treatments with chemotherapeutic drugs, such as cisplatin, and histone deacetyl...

Descripción completa

Detalles Bibliográficos
Autores principales: St Germain, Carly, O'Brien, Anna, Dimitroulakos, Jim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945341/
https://www.ncbi.nlm.nih.gov/pubmed/20828393
http://dx.doi.org/10.1186/1475-2867-10-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945341/
https://www.ncbi.nlm.nih.gov/pubmed/20828393
http://dx.doi.org/10.1186/1475-2867-10-32

Ejemplares similares